Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma-Reference-Cited by-同舟云学术

Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma

Published:2018-08 Issue:8 Volume:14 Page:
ISSN:1573-3882
Container-title:Metabolomics
language:en
Short-container-title:Metabolomics

Author:

Bayci A. W. L.,Baker D. A.,Somerset A. E.,Turkoglu O.,Hothem Z.,Callahan R. E.,Mandal R.,Han B.,Bjorndahl T.,Wishart D.,Bahado-Singh R.,Graham S. F.,Keidan R.

Publisher

Springer Science and Business Media LLC

Subject

Clinical Biochemistry,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/article/10.1007/s11306-018-1398-9/fulltext.html

Reference118 articles.

1. Abaffy, T., Möller, M. G., Riemer, D. D., Milikowski, C., & DeFazio, R. A. (2013). Comparative analysis of volatile metabolomics signals from melanoma and benign skin: A pilot study. Metabolomics, 9, 998–1008.

2. Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., et al. (2009). Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women. Journal of Nutrition, 139, 1073–1081.

3. Adrian, B. (1986). Arginine: Biochemistry, physiology, and therapeutic implications. Journal of Parenteral and Enteral Nutrition, 10, 227–238.

4. Agarwala, S. S. (2009). Current systemic therapy for metastatic melanoma. Expert Review of Anticancer Therapy, 9, 587–595.

5. Ananieva, E. (2015). Targeting amino acid metabolism in cancer growth and anti-tumor immune response. World Journal of Biological Chemistry, 6, 281–289.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act;Cancer Treatment Reviews;2024-09

2. Assessment of computational approaches in the prediction of spectrogram and chromatogram behaviours of analytes in pharmaceutical analysis: assessment review;Future Journal of Pharmaceutical Sciences;2023-10-12

3. Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanoma;OncoImmunology;2023-04-26

4. Increased Tryptophan, But Not Increased Glucose Metabolism, Predict Resistance of Pembrolizumab in Stage III/IV Melanoma;2022-12-07

5. Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma—Persistent Updating;Journal of Personalized Medicine;2022-09-14